Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir

Date:12/14/2022
Official Message No.:111615-12-14-2022-PHAD
Contact Info: Deepam | deepam.thomas@doh.nj.gov
Attachments: Yes Attachment 1

Seasonal influenza activity remains high across the United States and in New Jersey. While the Food and Drug Administration (FDA) has not indicated shortages of oseltamivir (generic or Tamiflu) in any of its forms (capsules, oral suspension), CDC and state health departments have received anecdotal reports of availability issues for generic oseltamivir in some locations. This may continue to occur in some communities as influenza activity continues.

 

The Centers for Disease Control and Prevention (CDC) has issued the attached health advisory that provides clinicians and public health officials with guidance for prioritizing oseltamivir for treatment and information on other influenza antivirals that are recommended for treating influenza in areas where oseltamivir is temporarily unavailable.

   

Please contact the Influenza Surveillance team at InfluenzaAdvisoryGroup@doh.nj.gov with any questions regarding this message. 

 


This information has been broadcast to: Day Care Centers / Preschools; School Administrators; School Nurses; Educational Institutions; Community Health Centers (FQHCs); Emergency Medical Services / First Responders; Long-term Care; Health Care Facilities / Other; Health Care Organizations; Health Care Providers; Hospital Staff Directory; Hospital Emerg Preparedness Coords; Hospital ER Medical Directors; Hospital Infection Control Practitioners; Hospital Medical Directors; Hospital Nursing Directors; Hospital Patient Safety Liaisons; Hospital Quality Liaisons; ICU Administrator; Lab Director; Hospitals / Other; Hospitals / Veterans; Labs / Non-Sentinel; Labs / Sentinel; Occupational Health Organizations; Local Boards of Health; Board of Public Utilities; Department of Children & Families; Department of Agriculture; Department of Community Affairs; Department of Corrections; Department of Education; Department of Environmental Protection; Department of Human Services; Department of Labor & Workforce Development; Department of Law and Public Safety; Department of Transportation; EMS Task Force; NJ Hospital Association; Office of Information Technology(OIT); Office of the Governor; New Jersey Departments & Agencies; DHSS Staff; NJDOH Staff; NJLINCS and Local Contacts; NJLINCS Community; Public Health Associations; Public Health Council; Hospitals / Acute Care; Hospital CEOs; Hospital Security Directors; Other State Partners; Alabama; Alaska; American Samoa; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; District of Columbia; Federated State of Micronesia; Florida; Georgia; Guam; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Marshalls Island; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hamsphire; New Jersey; New Mexico; New York; North Carolina; North Dakota; North Mariana Islands; Ohio; Oklahoma; Oregon; Palau; Pennsylvania; Puerto Rico; Rhode Island; South Carolina; South Dakota; Tennnesse; Texas; Utah; Vermont; Virgin Islands; Virginia; Washington; West Virginia; Wisconsin; Wyoming; Public Health Sector; Academic Leaders